title: [Contribution of gadolinium DOTA in primary tumors of bone and soft tissue].
abstract: 20 patients with a primary musculo skeletal tumor were investigated by MRI to assess the efficacy of Gd DOTA. The essential contribution is that it distinguishes the active parts of the lesion, intratumoral necrosis or sequelae cavities that do not take up the contrast medium. The injection does not allow for differentiation between tumor recurrence and treatment-induced inflammatory abnormality.
authors.affiliation: Institut Gustave-Roussy, Villejuif.
authors.forename: D
authors.initials: D
authors.lastname: Vanel
authors.forename: C
authors.initials: C
authors.lastname: Coffre
authors.forename: G
authors.initials: G
authors.lastname: Contesso
authors.forename: D
authors.initials: D
authors.lastname: Sarrazin
authors.forename: J
authors.initials: J
authors.lastname: Masselot
mesh_terms: D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000175:diagnosis*; D005069:Evaluation Studies as Topic; D005260:Female; D005682:Gadolinium; D006571:Heterocyclic Compounds; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D012983:Soft Tissue Neoplasms / Q000175:diagnosis*
chemical_list: D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium
vernacular_title: Apport du gadolinium DOTA dans 20 tumeurs primitives des os et des parties molles.